Free lung age calculator using the validated Morris-Temple (1985) clinical formula and an 8-factor lifestyle estimation mode for users without a spirometer. Find out how old your lungs really are, see your GOLD COPD staging, discover your predicted FEV1, and learn how your lung age improves when you stop smoking — backed by the Step2quit RCT published in the BMJ.
What Is Lung Age?
Lung age is a clinical concept that translates your spirometry result into a number that is far easier to understand than a litre value or a percentage. It is defined as the chronological age of a healthy, non-smoking person who has the same FEV1 (Forced Expiratory Volume in one second) as you. If you are 45 years old and your FEV1 matches the average for a healthy 60-year-old non-smoker, your lung age is 60 — your lungs are 15 years older than you are.
The concept was developed by Morris and Temple in 1985 and published in Preventive Medicine (PMID 4070195). It was designed specifically to make spirometry results meaningful to patients — particularly smokers who might dismiss an abstract litre value but respond to being told their lungs are functioning like those of someone 20 years older. Your chronological age — the foundation of this comparison — is precisely calculated using the ISO 8601 date arithmetic used across our platform. See our Age Calculator for the full chronological age breakdown used as the baseline for this tool.
The Morris-Temple Formula — Clinical Gold Standard
The lung age equation is derived by rearranging the reference spirometry equations used to predict FEV1 from age, sex, and height. The Morris-Temple (1985) formulas are:
Male: Lung Age = (0.0414 × Heightcm − 2.190 − FEV1measured) ÷ 0.0244
Female: Lung Age = (0.0342 × Heightcm − 1.578 − FEV1measured) ÷ 0.0255
The predicted FEV1 — what your lung volume should be for a healthy non-smoker of your age and height — is:
Male: FEV1predicted = 0.0414 × Heightcm − 0.0244 × Age − 2.190
Female: FEV1predicted = 0.0342 × Heightcm − 0.0255 × Age − 1.578
The calculator shows your measured FEV1 as a percentage of your predicted FEV1 (FEV1% predicted). This percentage is the key input for GOLD COPD staging — see below. If your FEV1% predicted is 80% or above, your lung function is within or near normal range. Below 50% indicates moderate to severe airflow limitation and warrants medical evaluation.
What Is FEV1 and How Is It Measured?
FEV1 stands for Forced Expiratory Volume in one second. It is the volume of air, measured in litres, that a person can forcibly exhale in the first second after taking a maximum inhalation. It is measured during a spirometry test — a simple, non-invasive lung function test performed by blowing forcefully into a spirometer device.
FEV1 is the most clinically relevant single measurement from spirometry because it is sensitive to airflow obstruction (the hallmark of COPD and asthma) while remaining relatively easy to measure accurately. Spirometry is available at most GP surgeries, pulmonology clinics, and hospital respiratory departments. The test typically takes 5–10 minutes and requires no preparation beyond avoiding heavy meals and intensive exercise in the hours before the test.
Normal FEV1 Values by Age and Sex
Predicted FEV1 varies with age, sex, and height. The following table shows approximate expected FEV1 values for healthy non-smokers of average height (175 cm for men, 163 cm for women). Individual values will vary. Enter your details into the clinical calculator above to get your personalised predicted FEV1.
| Age Group | Men (avg 175 cm) | Women (avg 163 cm) | Key note |
|---|---|---|---|
| 18–29 | 4.3–4.7 L | 3.1–3.4 L | Peak lung function decade |
| 30–39 | 4.0–4.4 L | 2.9–3.2 L | Gradual natural decline begins |
| 40–49 | 3.6–4.0 L | 2.7–3.0 L | ~25–30 ml/yr decline in non-smokers |
| 50–59 | 3.2–3.6 L | 2.4–2.7 L | Smoking accelerates to ~40–80 ml/yr decline |
| 60–69 | 2.7–3.1 L | 2.0–2.3 L | Significance of early intervention clear |
| 70–79 | 2.3–2.6 L | 1.7–2.0 L | Respiratory muscle weakness becomes factor |
Source: ATS/ERS Spirometry Standards; Morris-Temple reference equations. Values are approximate midpoints for average height adults.
GOLD COPD Staging — What Your FEV1% Predicted Means
The Global Initiative for Chronic Obstructive Lung Disease (GOLD 2024) classifies airflow obstruction into four stages based on FEV1% predicted following bronchodilator use. Our calculator uses pre-bronchodilator FEV1, so results should be treated as indicative rather than definitive. Only a physician can confirm a COPD diagnosis.
| GOLD Stage | FEV1% Predicted | Severity | Clinical Action |
|---|---|---|---|
| Normal / GOLD 1 | ≥80% | Mild or Normal | Monitor, lifestyle intervention if lung age elevated |
| GOLD 2 | 50–79% | Moderate | Medical evaluation, consider bronchodilator therapy |
| GOLD 3 | 30–49% | Severe | Pulmonologist referral, pulmonary rehabilitation |
| GOLD 4 | <30% | Very Severe | Urgent specialist care, possible supplemental oxygen |
Source: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2024 Guidelines. Available at goldcopd.org.
COPD affects over 300 million people globally and is the third leading cause of death worldwide according to the World Health Organization. In the United States alone, over 16 million adults have been diagnosed with COPD, with millions more undiagnosed. Early detection through spirometry — and communicating results as lung age — is one of the most effective tools for motivating behavioural change at the pre-symptomatic stage. If you have been diagnosed with COPD or another chronic lung condition, our Biological Age Calculator can give you a broader picture of how your respiratory health interacts with other markers of biological ageing.
The Science Behind Lung Age: The Step2quit Trial
The most compelling evidence for the clinical value of lung age comes from the Step2quit randomised controlled trial, published in the BMJ by Parkes et al. in 2008 (PMID 18326503). In this multicentre UK study, 561 smokers aged 35 and older were randomised to receive either their standard spirometry results or their spirometry results communicated as lung age.
The results were striking. At 12-month follow-up, verified smoking cessation rates were 13.6% in the lung age group versus 6.4% in the control group — more than double the quit rate. Telling patients their lung age was older than their chronological age provided a concrete, emotionally resonant motivation to quit that abstract percentage values did not. This is the evidence base for why lung age calculators are used in clinical practice and why our calculator shows the smoking cessation improvement timeline: because seeing a future projection of improvement is itself a powerful motivational tool.
Lung Age Without a Spirometer — The Lifestyle Estimation Mode
Not everyone has access to a spirometry test. Our lifestyle estimation mode provides an approximate lung age based on eight validated risk factors: smoking status and pack-years, exercise frequency, air pollution exposure, occupational dust and fume exposure, diagnosed respiratory conditions, BMI category, and frequency of chest infections. Each factor is weighted based on the published literature on its contribution to accelerated lung function decline.
This mode is educational and motivational — not a clinical measurement. The gold standard remains a spirometry test from your doctor or a respiratory clinic. However, the lifestyle mode can serve as a useful wake-up call, particularly for current or ex-smokers, those living in high-pollution urban environments, or people with occupational respiratory hazards who have never had formal lung function testing. It answers the question how old are my lungs likely to be? when a spirometer is not available. For cardiovascular health context alongside lung health, consider also using our Heart Age Calculator, which estimates cardiovascular age from similarly validated risk factors.
What Causes Accelerated Lung Ageing?
Cigarette smoking is by far the largest single cause of premature lung ageing. Smokers experience FEV1 decline at 40–80 ml per year compared to 20–30 ml per year in non-smokers. Over a 30-year smoking history of one pack per day (30 pack-years), this produces a cumulative FEV1 deficit of 600–1,500 ml — equivalent to 10–25 years of additional lung ageing.
Air pollution — both outdoor particulate matter (PM2.5 and PM10) and indoor pollutants (cooking fumes, mould, radon, second-hand smoke) — is the second largest contributor globally. The WHO estimates that 99% of the world's population breathes air that exceeds safe limits for at least one pollutant. Long-term exposure to PM2.5 above 10 μg/m³ is associated with significant FEV1 reduction comparable to several years of additional ageing.
Occupational exposures to organic dusts (grain, wood, cotton), mineral dusts (silica, asbestos, coal), and chemical fumes (welding, solvent, isocyanate exposure) cause accelerated lung function decline. Construction workers, miners, farmers, and manufacturing workers face substantially elevated risk. Proper respiratory protective equipment and workplace ventilation remain the primary prevention measures.
Uncontrolled asthma that is not treated appropriately can lead to airway remodelling over time, permanently reducing lung capacity. Treated and well-controlled asthma has far less impact on long-term FEV1 trajectory. This underscores the importance of regular inhaler use and adherence to prescribed asthma management plans.
Physical inactivity affects lung health through two mechanisms: reduced respiratory muscle strength and the broader metabolic effects of sedentary behaviour on systemic inflammation. Aerobic exercise strengthens the diaphragm and intercostal muscles, maintains chest wall compliance, and reduces inflammatory markers associated with lung tissue damage.
How to Improve Your Lung Age
The most powerful intervention for improving lung age is smoking cessation. Within one year of quitting, the rate of FEV1 decline returns toward the non-smoker trajectory. Cumulative recovery over 5–10 years can reduce lung age by several years. The Step2quit trial showed that communicating this possibility — making the improvement tangible and time-stamped — is itself a powerful quit-smoking motivator.
Aerobic exercise at moderate-to-vigorous intensity for at least 150 minutes per week strengthens respiratory muscles, improves diaphragmatic efficiency, and has been shown in multiple studies to improve FEV1 by 5–10% in individuals with mild-to-moderate COPD over 8–12 weeks of supervised pulmonary rehabilitation.
Breathing exercises — particularly diaphragmatic (belly) breathing and pursed-lip breathing — are components of pulmonary rehabilitation programmes and help reduce the sensation of breathlessness, improve oxygen exchange efficiency, and reduce respiratory rate at rest.
Vaccination against influenza and pneumococcal pneumonia prevents respiratory infections that can cause permanent lung tissue damage, particularly in older adults and those with pre-existing lung conditions. The annual flu vaccine is recommended by the WHO for all adults over 65 and for younger adults with chronic respiratory disease.
For a comprehensive view of how your overall biological age compares to your chronological age — encompassing cardiovascular, metabolic, and musculoskeletal health alongside respiratory function — use our Biological Age Calculator and Metabolic Age Calculator.
Frequently Asked Questions
What is a normal lung age?
A normal lung age is equal to or lower than your chronological age. If you are 45 years old and your lung age is 44 or 45, your FEV1 is at or above the expected level for a healthy non-smoker of your age and height. A lung age higher than your chronological age indicates that your FEV1 has fallen below the norm for your age group, which may reflect the effects of smoking, air pollution, chronic disease, or other factors.
How accurate is a lung age calculator?
The clinical mode using FEV1 is based on the Morris-Temple validated regression equations and is accurate to within approximately 5 years for most adults between 18 and 70. Accuracy is lower at the extremes of age and height. The lifestyle estimation mode provides a directional estimate only and should not be used as a substitute for spirometry. For any clinical decision — including COPD management — spirometry performed by a trained technician with a calibrated spirometer remains the gold standard.
Can lung age be improved?
Yes. The most impactful improvement comes from stopping smoking: within one year, the accelerated rate of FEV1 decline slows to the non-smoker trajectory, and there is gradual partial recovery over the following 5–10 years. Regular aerobic exercise, reduced exposure to air pollution, treatment of underlying respiratory conditions (asthma, allergic rhinitis), and annual vaccination against respiratory infections all contribute to better long-term lung function maintenance.
What does it mean if my lung age is 20 years older than my real age?
A lung age 20 years above your chronological age indicates that your FEV1 has fallen significantly below the expected level for a healthy non-smoker of your age. This level of discrepancy is associated with GOLD 2–3 COPD staging in spirometry and represents significant airflow limitation. Immediate medical evaluation is strongly advised. Smoking cessation at this stage can still substantially slow further decline. Do not delay seeking professional medical advice if your result shows a large lung age gap.
Does smoking cessation reverse lung age?
Cessation does not fully reverse the damage already done, but it does halt the accelerated decline. A smoker's FEV1 drops at 40–80 ml/year; after quitting, the rate returns to the non-smoker rate of 20–30 ml/year. Some recovery of FEV1 occurs over the first 1–2 years post-cessation as airway inflammation reduces and mucus clearance improves. The earlier cessation occurs, the greater the long-term benefit. The Step2quit trial showed that patients told their lung age were more than twice as likely to have quit at 12 months compared to those given standard spirometry results alone.
What is the difference between FEV1 and FVC?
FEV1 (Forced Expiratory Volume in 1 second) measures how much air you can forcibly exhale in the first second. FVC (Forced Vital Capacity) measures the total volume of air exhaled over the complete breath. The FEV1/FVC ratio is the key diagnostic metric: a ratio below 0.70 (70%) after bronchodilator use confirms obstructive lung disease such as COPD. A low FVC with a normal or high FEV1/FVC ratio suggests restrictive lung disease. This calculator uses FEV1 for lung age calculation — the metric for which the Morris-Temple formula was specifically derived.
What is a pack-year?
A pack-year is a unit measuring cumulative tobacco smoke exposure. One pack-year equals smoking one pack (20 cigarettes) per day for one year. A person who smoked half a pack per day for 30 years has 15 pack-years. Pack-years correlate strongly with COPD risk: the GOLD guidelines use pack-year history as a key risk stratification tool, with significant risk beginning at approximately 10 pack-years and substantially elevated risk above 30 pack-years.
Can I use this lung age calculator for children?
No. The Morris-Temple formula was derived from adult data and applies to ages 18 and above. Paediatric lung function testing uses different reference equations (Global Lung Function Initiative equations cover ages 3–95) that account for the growth trajectory of lung function in children and adolescents. If you need to assess a child's developmental progress or age-appropriate milestones, our Developmental Age Calculator covers age-based development assessment for younger individuals.